• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21720 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for advanced or metastatic malignant melanoma with a c-kit juxtamembrane mutation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ciraparantag for haemorrhage in patients receiving new oral anticoagulants
2006     NIHR Horizon Scanning Centre (NIHR HSC) Nimotuzumab (Theraloc) for glioma: horizon scanning technology briefing
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for follicular non-Hodgkin's lymphoma - refractory
2012     NIHR Horizon Scanning Centre (NIHR HSC) Darbepoetin alfa (Aranesp) for anaemia in symptomatic heart failure
2014     NIHR Horizon Scanning Centre (NIHR HSC) Abaloparatide for postmenopausal osteoporosis – first and second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Olaparib (Lynparza) for metastatic breast cancer with germline BRCA mutation – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Autologous CD34+ hematopoietic stem cells transduced ex vivo with lentiviral vector encoding for the human ADA gene for severe combined immunodeficiency caused by adenosine deaminase deficiency
2006     NIHR Horizon Scanning Centre (NIHR HSC) Nilotinib (AMN-107) for imatinib-resistant chronic myeloid leukaemia: horizon scanning technology ultra-orphan note
2009     NIHR Horizon Scanning Centre (NIHR HSC) Patupilone (EPO906) for recurrent epithelial ovarian cancer - refractory and/or resistant
2012     NIHR Horizon Scanning Centre (NIHR HSC) Edoxaban tosylate for the treatment and secondary prevention of venous thromboembolic events
2014     NIHR Horizon Scanning Centre (NIHR HSC) Idalopirdine for Alzheimer's disease as an adjunct to acetylcholinesterase inhibitor therapy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent PD-L1 positive non-small cell lung cancer – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Diazoxide choline controlled-release for Prader-Willi syndrome – first line
2006     NIHR Horizon Scanning Centre (NIHR HSC) Citrasate dialysate for patients with chronic or acute renal failure requiring long-term haemodialysis: horizon scanning technology briefing
2009     NIHR Horizon Scanning Centre (NIHR HSC) Pirfenidone for idiopathic pulmonary fibrosis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dalcetrapib for the prevention of cardiovascular events
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pimavanserin tartrate for psychosis associated with Parkinson's disease - first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent non-small cell lung cancer – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for relapsing neuromyelitis optica spectrum disorders
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for prevention and treatment of bleeding in patients with underlying disease - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Quetiapine (Seroquel XL) for major depressive disorder
2011     NIHR Horizon Scanning Centre (NIHR HSC) Edoxaban tosylate for prevention of stroke and systemic embolic events in non-valvular atrial fibrillation
2014     NIHR Horizon Scanning Centre (NIHR HSC) Daclizumab High Yield Process for relapsing forms of multiple sclerosis – first or second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Rucaparib for advanced BRCA-mutated ovarian cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) XG 102 for post-operative inflammation and pain following cataract surgery
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for life-threatening surgical and traumatic bleeding in non-haemophiliacs - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for macular oedema secondary to central or branch retinal vein occlusion
2011     NIHR Horizon Scanning Centre (NIHR HSC) HHLivC (Human Heterologous Liver Cells) for urea cycle disorders
2014     NIHR Horizon Scanning Centre (NIHR HSC) Fingolimod for chronic inflammatory demyelinating polyneuropathy – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for relapsed or refractory multiple myeloma
2016     NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for prevention of delayed graft function after kidney transplantation in adult patients at increased risk – first line
2003     NIHR Horizon Scanning Centre (NIHR HSC) Azacitidine and decitabine for myelodysplastic syndrome - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for diabetic macular oedema
2012     NIHR Horizon Scanning Centre (NIHR HSC) EyeOP1® for glaucoma
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ocrelizumab for relapsing-remitting multiple sclerosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for platinum-resistant, recurrent or metastatic head and neck cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) Molgramostim inhalation for autoimmune pulmonary alveolar proteinosis
2003     NIHR Horizon Scanning Centre (NIHR HSC) Deferasirox (ICL 670) for iron overload - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Retigabine for partial onset epilepsy - refractory
2011     NIHR Horizon Scanning Centre (NIHR HSC) IRay™ for wet age related macular degeneration
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ocrelizumab for primary progressive multiple sclerosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) AM-111 for acute sensorineural hearing loss - first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Cryopreserved human placental tissue (Stravix) for wound repair
2003     NIHR Horizon Scanning Centre (NIHR HSC) Porfimer sodium photodynamic therapy for high-grade dysplasia of Barrett's oesophagus - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sativex for adults experiencing pain from cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Curelator Headache™ digital platform for adults with migraine
2016     NIHR Horizon Scanning Centre (NIHR HSC) Tremelimumab for unresectable pleural or peritoneal malignant mesothelioma – second and third line
2003     NIHR Horizon Scanning Centre (NIHR HSC) Meniett low-pressure pulse generator for Meniere's disease - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) for transitional cell carcinoma of the urothelial tract - second line
2011     NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
2014     NIHR Horizon Scanning Centre (NIHR HSC) SensiumVitals® vital signs monitoring patch
2016     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line
2009     NIHR Horizon Scanning Centre (NIHR HSC) Afamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria
2011     NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (MabThera) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Peramivir for acute uncomplicated influenza in adults
2016     NIHR Horizon Scanning Centre (NIHR HSC) Eteplirsen for Duchenne muscular dystrophy in patients amenable to exon 51 skipping
2009     NIHR Horizon Scanning Centre (NIHR HSC) Alipogene tiparvovec (AMT-011, Glybera) for lipoprotein lipase deficiency
2011     NIHR Horizon Scanning Centre (NIHR HSC) Odanacatib for post-menopausal osteoporosis – first or second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ivacaftor (Kalydeco) for an additional 8 mutations in cystic fibrosis (licence extension)
2016     NIHR Horizon Scanning Centre (NIHR HSC) DMI-9523 (Ampion) for moderate to severe osteoarthritis of the knee
2009     NIHR Horizon Scanning Centre (NIHR HSC) Clopidogrel (Plavix) for neonates and infants with cyanotic congenital heart disease who have undergone a palliative shunt procedure
2011     NIHR Horizon Scanning Centre (NIHR HSC) Tocilizumab (RoACTEMRA) for early rheumatoid arthritis not treated with methotrexate – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) InterVapor® System for the treatment of severe emphysema
2016     NIHR Horizon Scanning Centre (NIHR HSC) SPK-RPE65 gene therapy for inherited retinal dystrophies due to mutations in the RPE65 gene
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for fludarabine-refractory chronic lymphocytic leukaemia - second or third-line
2011     NIHR Horizon Scanning Centre (NIHR HSC) VEGF trap-eye (Eylea) for macular oedema secondary to central retinal vein occlusion - first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Dexamethasone sodium phosphate (EryDex) for ataxia telangiectasia – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ivermectin 1% topical cream for papulopustular rosacea
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lebrikizumab for severe asthma – second line
2009     NIHR Horizon Scanning Centre (NIHR HSC) Omalizumab (Xolair) for severe persistent allergic asthma in children
2011     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for advanced and/or metastatic translocation-related sarcomas - first line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dimethyl fumarate for relapsing-remitting multiple sclerosis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for epidermolysis bullosa
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pitolisant hydrochloride for obstructive sleep apnoea
2007     NIHR Horizon Scanning Centre (NIHR HSC) Amplichip (CYP40 test) for breast cancer - determine sensitivity to tamoxifen: horizon scanning technology briefing
2009     NIHR Horizon Scanning Centre (NIHR HSC) Silodosin for benign prostatic hyperplasia
2011     NIHR Horizon Scanning Centre (NIHR HSC) Olesoxime for amyotrophic lateral sclerosis - first line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Lacosamide (Vimpat) for epilepsy – first and second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) CelluTome™ epidermal harvesting system for autologous skin grafting
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ace-ER (aceneuramic acid - extended release) for GNE myopathy
2007     NIHR Horizon Scanning Centre (NIHR HSC) MammaPrint prognostic test for breast cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for metastatic gastric cancer - first line in combination with capecitabine and cisplatin
2011     NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for axial spondyloarthritis - second line
2012     NIHR Horizon Scanning Centre (NIHR HSC) DELFIA® Xpress PlGF kit antenatal screening test to predict risk of pre-eclampsia
2007     NIHR Horizon Scanning Centre (NIHR HSC) Degarelix depot (Firmagon) for advanced, hormone-dependent prostate cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2011     NIHR Horizon Scanning Centre (NIHR HSC) Liraglutide (Victoza) in combination with basal insulin for type 2 diabetes
2012     NIHR Horizon Scanning Centre (NIHR HSC) Umeclidinium and vilanterol for chronic obstructive pulmonary disease
2014     NIHR Horizon Scanning Centre (NIHR HSC) Dinutuximab (Unituxin) for high risk neuroblastoma – maintenance therapy
2008     NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Agento I.C for ventilator associated pneumonia
2011     NIHR Horizon Scanning Centre (NIHR HSC) Eslicarbazepine acetate (Zebinix) for partial onset seizures in epilepsy - monotherapy
2011     NIHR Horizon Scanning Centre (NIHR HSC) Alair® Bronchial Thermoplasty System for severe asthma
2014     NIHR Horizon Scanning Centre (NIHR HSC) Blinatumomab for relapsed or refractory Philadelphia-negative B-precursor acute lymphoblastic leukaemia
2007     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab (Herceptin) for advanced gastric cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Radachlorin photodynamic therapy for basal cell carcinoma
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dapagliflozin and metformin fixed-dose combination for type 2 diabetes
2014     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for early HER2-positive breast cancer, neoadjuvant therapy in combination with trastuzumab